ArticleCancer immunology research2026
MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9⁺ monocyte-macrophage programming and durable antitumor immunity in triple negative breast cancer.
Alex J Smith et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.